Journal ArticleOPEN ACCESS

Prostate cancer SubtyPINg BiomarKers and outcome: Is clarity EmERGing?

Clinical Cancer Research (2014) 20(18) 4733-4736
DOI: 10.1158/1078-0432.CCR-14-0818
16Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Molecular prostate cancer subtypes have been proposed on the basis of mutually exclusive SPINK1 and ERG overexpression, with conflicting reports on their prognostic ability. Flavin and colleagues report that SPINK1 is neither prognostic nor absolutely mutually exclusive with ERG, raising important questions about prostate cancer molecular subtyping and prognostic biomarker evaluation.

Cite

CITATION STYLE

APA

Smith, S. C., & Tomlins, S. A. (2014). Prostate cancer SubtyPINg BiomarKers and outcome: Is clarity EmERGing? Clinical Cancer Research, 20(18), 4733–4736. https://doi.org/10.1158/1078-0432.CCR-14-0818

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free